Injective (INJ) climbed 9% to $4.73 on Wednesday, pushing its relative strength index to 79.88 — a level traders often read as overbought. The move comes as technical momentum and institutional positioning point to a possible 16% rally to $5.50 within the next two weeks, according to market data.
Overbought reading raises caution
The RSI, a tool that measures the speed and size of price changes, now sits above 70 — the threshold most traders consider overbought. Readings above 80 can signal an asset is stretched and due for a pullback. At 79.88, INJ is close to that line, suggesting the current rally may be running out of steam in the short term.
Despite the overbought warning, the token’s price action has been driven by what analysts describe as technical momentum and institutional positioning. The exact nature of that positioning wasn't disclosed, but it typically involves large-scale buyers accumulating positions through OTC desks or spot markets.
Why $5.50 is the next target
Based on the breakout pattern and volume profile, the next resistance level sits at $5.50. That would represent a 16% gain from Wednesday’s $4.73 close. The timeline for that move is roughly two weeks, assuming the current trend holds.
But the same analysis predicts a correction once that target is hit. Overbought conditions, combined with profit-taking near resistance, could push the price back down. Whether that correction is sharp or shallow depends on whether institutional buyers continue to accumulate or start taking profits.
What a correction could look like
A pullback from $5.50 would likely bring INJ back toward the $4.20–$4.50 range, where it found support before the latest surge. Traders will be watching volume and order book data for signs of selling pressure as the price approaches the target.
For now, the rally has been orderly. The 9% gain was accompanied by increasing volume, which adds credibility to the move. But the RSI reading means the token is entering territory where sharp reversals are common. The next two weeks will tell whether the $5.50 target is reached and how deep the subsequent correction goes.
